Kolaleh Eskandanian, chief innovation officer at Children’s National Hospital, said the partnership is meant to address the ...

Multibillion-dollar buyouts returned last year, led by Johnson & Johnson’s $13.1 billion acquisition of Shockwave Medical.

Abbott and Dexcom settled all patent lawsuits related to continuous glucose monitors (CGMs). The two competitors, who lead ...

Inspectors found 111 open tickets for software defects categorized as catastrophic or severe patient harm. Several safety ...

From challenging market leaders to the growing influence of artificial intelligence, medical device executives had a lot to ...

Edwards submitted a request for a national coverage determination in February, after receiving FDA approval for its Evoque ...

Just in time for the holiday season, ZuriMED Technologies AG celebrated a significant achievement: FDA clearance of their 510 ...

IPOs in medtech have been sparse, but some analysts said improving market conditions could support a revival of offerings in ...

Medtech regulators and watchdogs took a closer look at recalls in 2024. Here’s a recap of notable recalls and product safety actions in the past year.

Dexcom received FDA clearance in March for the first over-the-counter glucose monitor, called Stelo. It’s cleared for adults who don’t take insulin, including people with Type 2 diabetes. The wellness ...